These data suggest that reduced GH-IGF-1/insulin signaling protects from cancer in part by reducing DNA damage and in part by increasing apoptosis in damaged cells, making the link between decreased activity of growth signaling pathways and DNA protection or repair mechanisms conserved from yeast to humans. The gene discussed is GH1; the disease is cancer.